Neoadjuvant hormonal therapy: The Canadian experience

This publication has 24 references indexed in Scilit:

• Cancer statistics, 1996
  CA: A Cancer Journal for Clinicians, 1996
• Effect of Neoadjuvant Endocrine Therapy (Combined Androgen Blockade) on Normal Prostate and Prostatic Carcinoma
  The American Journal of Surgical Pathology, 1996
• Down-staging of early stage prostate cancer before radical prostatectomy: The first randomized trial of neoadjuvant combination therapy with flutamide and a luteinizing hormone-releasing hormone agonist
  Urology, 1994
• Pathologic and clinical findings to predict tumor extent of nonpalpable (stage T1c) prostate cancer
  Published by American Medical Association (AMA) ,1994
• Cancer statistics, 1994
  CA: A Cancer Journal for Clinicians, 1994
• Clinical stage Bo or T1c prostate cancer: Nonpalpable disease identified by elevated serum prostate-specific antigen concentration
  Urology, 1993
• Measurement of Prostate-Specific Antigen in Serum as a Screening Test for Prostate Cancer
  New England Journal of Medicine, 1991
• Prostate Cancer Consensus Hampered by Lack of Data
  Science, 1987
• Understaging and undergrading of prostate cancer Argument for postoperative radiation as adjuvant therapy
  Urology, 1983
• The palpable nodule of prostatic cancer. Results 15 years after radical excision
  JAMA, 1968